| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | ||
|---|---|---|---|---|---|---|
Revenue | ||||||
0 | 0 | - | - | - | ||
Research and development expenses | ||||||
8,680 | 5,771 | 2,395 | 2,496 | 1,398 | ||
General and administrative expenses | ||||||
6,063 | 7,450 | 7,685 | 4,129 | 3,330 | ||
Fair value adjustment, contingent consideration | ||||||
0 | -210 | -140 | 300 | 0 | ||
Total operating expense | ||||||
14,743 | 13,431 | - | - | - | ||
Loss from operations | ||||||
- | - | -10,221 | -6,325 | -4,728 | ||
Other: | ||||||
Interest expense | ||||||
433 | 101 | 875 | 5,937 | 1,587 | ||
Fair value adjustment, warrants | ||||||
- | - | - | -2,329 | 386 | ||
Other income | ||||||
- | - | - | 2,329 | -0 | ||
Total other | ||||||
433 | 101 | 875 | 8,266 | 1,201 | ||
Loss before income taxes | ||||||
- | - | - | -14,591 | -5,930 | ||
Income taxes | ||||||
- | - | - | 0 | 0 | ||
Net loss | ||||||
-15,177 | -13,533 | -11,096 | -14,591 | -5,930 | ||
Other comprehensive loss: | ||||||
Foreign currency translation adjustment | ||||||
-116 | -194 | 506 | -115 | -596 | ||
Total comprehensive loss | ||||||
-15,294 | -13,728 | -10,590 | -14,707 | -6,526 | ||
Basic and diluted weighted average shares outstanding | ||||||
-0 | -0 | 10,628 | 6,504 | 3,627 | ||
Loss per share - basic and diluted | ||||||
22,425,564.00 | 15,439,310.00 | -1.04 | -2.24 | -1.63 | ||